November will bring an epic battle for both the U.S. presidency and control in Congress, both of which could have [...] …
Category: General
German drugmaker Bayer will no longer exempt federal grantees from its 340B contract pharmacy policy beginning Oct. 1—the same day [...] …
The 340B program’s growth in recent decades has helped it attract a growing number of corporate and private equity investments, [...] …
French drugmaker Sanofi has reportedly asked some hospitals for data relating to 340B purchases of a popular drug used to [...] …
More transparency surrounding 340B hospital operations is needed to ensure drug discount savings are being used to improve patient care, [...] …
A major hospital advocacy group recently urged congressional advisers to “carefully consider” the potential negative consequences of any new efforts [...] …
GlaxoSmithKline (GSK) will refund covered entities that purchased certain formulations of a severe asthma treatment medication in the third quarter [...] …
340B covered entities could soon be required to share new information—including reimbursement amounts, ship to dates and ship to locations—as [...] …
A former Pfizer executive and current biopharmaceutical consultant took aim this week at what she called the “poorly managed” 340B [...] …
Although Massachusetts lawmakers left Beacon Hill this month without passing a long-stalled 340B contract pharmacy access bill, provider groups say [...] …